Axonics Provides Update on Inter Partes Review Proceedings
Axonics, Inc. (AXNX)
Last axonics, inc. earnings: 3/4 04:01 pm
Check Earnings Report
Company Research
Source: Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued written decisions on two Medtronic patents that Axonics is contesting.The PTAB issued its decision with respect to Patent Nos. 8,626,314 (“the ‘314 patent”) and 8,036,756 (“the ‘756 patent”). Medtronic has asserted these patents, which expired in 2021 and 2022, against Axonics’ proprietary tined lead design. Today, the PTAB invalidated 10 of the 15 challenged claims in Medtronic’s ‘314 patent and declined to invalidate the challenged claims in the ‘756 patent over one Administrative Patent Judge’s dissenting opinion. The district court case where Medtronic has asserted these patents is currently stayed based on these IPRs as well as pending IPRs on other Medtronic asserted patents. Axonics plans to seek review of the PTAB’s finding that the remaining claims were not unpatentable.“We are pleased with the PTAB’
Show less
Read more
Impact Snapshot
Event Time:
AXNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXNX alerts
High impacting Axonics, Inc. news events
Weekly update
A roundup of the hottest topics
AXNX
News
- Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash [Seeking Alpha]Seeking Alpha
- FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal [Reuters]Reuters
- FTC seeks additional information for Boston Scientific's $3.7 bln Axonics deal [Yahoo! Finance]Yahoo! Finance
- UPDATE 1-FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal [Yahoo! Finance]Yahoo! Finance
- All You Need to Know About Axonics (AXNX) Rating Upgrade to Buy [Yahoo! Finance]Yahoo! Finance
AXNX
Earnings
- 10/30/23 - Beat
AXNX
Sec Filings
- 4/4/24 - Form 8-K
- 3/25/24 - Form 8-K
- 3/7/24 - Form DEFA14A
- AXNX's page on the SEC website